John Kristen, Huntress Ian, Smith Ethan, Chou Hsuan, Tollison Tammy S, Covarrubias Sergio, Crisci Elisa, Carpenter Susan, Peng Xinxia
Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
Genetics & Genomics Graduate Program, North Carolina State University, Raleigh, North Carolina, USA.
J Virol. 2025 Apr 15;99(4):e0014125. doi: 10.1128/jvi.00141-25. Epub 2025 Mar 25.
Long noncoding RNAs (lncRNAs) are a newer class of noncoding transcripts identified as key regulators of biological processes. Here, we aimed to identify novel lncRNA targets that play critical roles in major human respiratory viral infections by systematically mining large-scale transcriptomic data sets. Using bulk RNA-sequencing (RNA-seq) analysis, we identified a previously uncharacterized lncRNA, named virus-inducible lncRNA modulator of interferon response (), that was consistently upregulated after influenza infection across multiple human epithelial cell lines and influenza A virus subtypes. was also upregulated after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and respiratory syncytial virus (RSV) infections . We experimentally confirmed the response of to influenza infection and interferon-beta (IFN-β) treatment in the A549 human epithelial cell line and found the expression of was robustly induced by IFN-β treatment in a dose- and time-specific manner. Single-cell RNA-seq analysis of bronchoalveolar lavage fluid samples from coronavirus disease 2019 (COVID-19) patients uncovered that was upregulated across various cell types, including at least five immune cells. The upregulation of in immune cells was further confirmed in the human T cell and monocyte cell lines, SUP-T1 and THP-1, after IFN-β treatment. Finally, we found that knockdown of expression reduced the magnitude of host transcriptional responses to both IFN-β treatment and influenza A virus infection in A549 cells. Together, our results show that is a novel interferon-stimulated gene (ISG) that regulates the host interferon response and may be a potential therapeutic target for human respiratory viral infections upon further mechanistic investigation.IMPORTANCEIdentifying host factors that regulate the immune response to human respiratory viral infection is critical to developing new therapeutics. Human long noncoding RNAs (lncRNAs) have been found to play key regulatory roles during biological processes; however, the majority of lncRNA functions within the host antiviral response remain unknown. In this study, we identified that a previously uncharacterized lncRNA, virus-inducible lncRNA modulator of interferon response (), is upregulated after major respiratory viral infections including influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus. We demonstrated that is an interferon-stimulated gene that is upregulated after interferon-beta (IFN-β) in several human cell types. We also found that knockdown of reduced the magnitude of host transcriptional responses to IFN-β treatment and influenza A infection in human epithelial cells. Our results reveal that regulates the host interferon response and may present a new therapeutic target during human respiratory viral infections.
长链非编码RNA(lncRNAs)是一类新发现的非编码转录本,被确定为生物过程的关键调节因子。在此,我们旨在通过系统挖掘大规模转录组数据集,鉴定在人类主要呼吸道病毒感染中起关键作用的新型lncRNA靶点。通过批量RNA测序(RNA-seq)分析,我们鉴定出一种以前未被表征的lncRNA,命名为干扰素反应的病毒诱导性lncRNA调节因子( ),在多种人类上皮细胞系和甲型流感病毒亚型中,甲型流感感染后该因子持续上调。在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和呼吸道合胞病毒(RSV)感染后, 也上调。我们通过实验证实了A549人类上皮细胞系中 对甲型流感感染和干扰素-β(IFN-β)治疗的反应,发现IFN-β治疗以剂量和时间特异性方式强烈诱导了 的表达。对2019冠状病毒病(COVID-19)患者支气管肺泡灌洗液样本的单细胞RNA-seq分析发现, 在包括至少五种免疫细胞在内的各种细胞类型中均上调。在IFN-β治疗后,人类T细胞和单核细胞系SUP-T1和THP-1中免疫细胞中 的上调得到进一步证实。最后,我们发现敲低 表达降低了A549细胞中宿主对IFN-β治疗和甲型流感病毒感染的转录反应强度。总之,我们的结果表明, 是一种新型干扰素刺激基因(ISG),可调节宿主干扰素反应,经过进一步的机制研究后可能成为人类呼吸道病毒感染的潜在治疗靶点。
鉴定调节人类呼吸道病毒感染免疫反应的宿主因子对于开发新疗法至关重要。已发现人类长链非编码RNA(lncRNAs)在生物过程中起关键调节作用;然而,大多数lncRNA在宿主抗病毒反应中的功能仍不清楚。在本研究中,我们鉴定出一种以前未被表征的lncRNA,干扰素反应的病毒诱导性lncRNA调节因子( ),在包括甲型流感、严重急性呼吸综合征冠状病毒2和呼吸道合胞病毒在内的主要呼吸道病毒感染后上调。我们证明 是一种干扰素刺激基因,在几种人类细胞类型中,经干扰素-β(IFN-β)作用后上调。我们还发现敲低 可降低人类上皮细胞中宿主对IFN-β治疗和甲型流感感染的转录反应强度。我们的结果表明, 调节宿主干扰素反应,可能是人类呼吸道病毒感染期间的一个新的治疗靶点。